Compositionally and quality-wise, this result actually doesn't look too bad. But the outlook commentary is very cautious. Business conditions for the bank have clearly slowed, judging by the tone and content of the report.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025